SMARAGD enhances communication between patients and radiologists through an intuitive, AI-driven chatbot. It improves patient engagement and satisfaction, leading to more personalized and effective care.
The SMARAGD framework transforms free-text mammography reports using BI-RADS (Breast Imaging-Reporting and Data System), ACR (American College of Radiology) and standard cancer terminology.
SMARAGD software detects medical inconsistencies using Common Data Elements (CDEs) and AI, ensuring accurate, reliable healthcare data analysis. This integration streamlines clinical workflows, enhancing patient safety and care quality.
SMARAGD accelerates data intake and improves accuracy. Our platform brings patients closer to radiologists through an integrated chatbot, facilitating seamless communication.
Employs a robust Common Data Elements (CDE) framework, ensuring comprehensive, and interoperable data collection. This enables precise data analysis and Ai integration.
Combined with Fast Healthcare Interoperability Resources (FHIR) integration, SMARAGD ensures seamless data exchange and compatibility across healthcare systems.
Innosuisse is the Swiss Innovation Agency, dedicated to promoting science-based innovation in the interest of the economy and society. It provides funding, support, and networking opportunities to help businesses and researchers develop groundbreaking projects and bring innovative solutions to market.
The radiology and radiation oncology departments are actively participating in this project, bringing their expertise to the forefront. Their involvement ensures the integration of cutting-edge medical practices and enhances the effectiveness of our commonly created software solution.
The Berne University of Applied Sciences (BfH) excels in fields such as business, health, and engineering. BfH emphasizes innovative teaching methods, close industry collaboration, and sustainability. The university provides a dynamic scientific and educational environment with modern facilities. For SMARAGD, the BfH mainly contributed in creation of the INSELBert model.
Sitem-insel focuses on translational and clinical research in medical technology. It aims to bridge the gap between innovative research and practical healthcare applications. The center provides advanced research facilities, fosters collaboration between academia and industry, and supports the development of medical devices and technologies from conception to market readiness.
Switzerland Innovation Park fosters collaboration between companies, startups, and universities to address global challenges through innovation. It provides an ecosystem that accelerates the transformation of research into marketable products and services.
Sitem-insel focuses on translational and clinical research in medical technology. It aims to bridge the gap between innovative research and practical healthcare applications. The center provides advanced research facilities, fosters collaboration between academia and industry, and supports the development of medical devices and technologies from conception to market readiness.
ID Suisse AG specializes in medical software solutions, focusing on improving healthcare administration and clinical processes. Their products include tools for data collection, billing, controlling, electronic medication, and natural language processing. The company's innovations, like AI and machine learning, enhance efficiency and accuracy in medical coding and administrative tasks.
Wemedoo specializes in developing digital health innovations that enable full medical data interoperability. They offer integrated services for clinical trials, medical devices, and real-world data collection, aiming to enhance data quality, flexibility, and generate actionable insights across biomedical research and clinical practice.
Subscribe to our Newsletter
